Drawing for CENTELION

USPTO serial 79009687

CENTELION

Reviewed by CopyMark Law Group

Reg. 3114451Status 404
Filing date
Status date
Registration date
Jul 11, 2006
Examiner
GILBERT, REBECCA L
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CENTELION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Susan Upton Douglass

SUSAN UPTON DOUGLASS FROSS ZELNICK LEHRMAN & ZISSU PC866 UNITED NATIONS PLZNEW YORK, NY 10017UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceuticals used in gene and cell therapy for treating oncologic, cardiovascular, immunological, respiratory, central nervous system or psychologic disordersSECTION 71 - CANCELLED—
042pharmaceutical, medical and scientific research and development services for new productsSECTION 71 - CANCELLED—
044medical care in connection with gene and cell therapiesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 11, 2015DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Jun 11, 2015DETHDEATH OF INTERNATIONAL REGISTRATION—
Jun 6, 2014INNTTOTAL INVALIDATION PROCESSED BY THE IB—
May 13, 2014INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
May 13, 2014INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 13, 2013C71TCANCELLED SECTION 71—
Apr 18, 2008FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 16, 2007FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 16, 2007FIMPFINAL DISPOSITION PROCESSED—
Mar 13, 2007FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 11, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 18, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 29, 2006NPUBNOTICE OF PUBLICATION—
Feb 27, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 24, 2006ALIEASSIGNED TO LIE—
Feb 21, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 3, 2006ACECAMENDMENT FROM APPLICANT ENTERED—
Jan 20, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 20, 2006MAILPAPER RECEIVED—
Aug 4, 2005RFNTREFUSAL PROCESSED BY IB—
Jul 19, 2005RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 6, 2005RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 5, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 29, 2005DOCKASSIGNED TO EXAMINER—
Apr 29, 2005NWAPNEW APPLICATION ENTERED—
Apr 28, 2005REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance